The Incretins and Pancreatic β-Cells: Use of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide to Cure Type 2 Diabetes Mellitus
Mi-Hyun Kim (Kim MH), Moon-Kyu Lee (Lee MK)
Korean Diabetes J. 2010;34(1):2-9.   Published online 2010 Feb 28     DOI: https://doi.org/10.4093/kdj.2010.34.1.2
Citations to this article as recorded by Crossref logo
Misregulation of Wnt Signaling Pathways at the Plasma Membrane in Brain and Metabolic Diseases
Mustafa Karabicici, Yagmur Azbazdar, Evin Iscan, Gunes Ozhan
Membranes.2021; 11(11): 844.     CrossRef
Effects of newly introduced antidiabetic drugs on autophagy
Milad Ashrafizadeh, Habib Yaribeygi, Stephen L. Atkin, Amirhossein Sahebkar
Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(4): 2445.     CrossRef
Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses
Kanwal Rehman, Mehwish Bagh Ali, Muhammad Sajid Hamid Akash
Biomedicine & Pharmacotherapy.2019; 112: 108670.     CrossRef
Liraglutide vs Exenatide: Patient Adherence, Medication Persistence and Economic Evaluation in the Treatment of Type 2 Diabetes Mellitus
Fiorenzo Santoleri, Paola Sorice, Ruggero Lasala, Alberto Costantini
Pharmacology & Pharmacy.2014; 05(04): 332.     CrossRef
Metformin enhances glucagon-like peptide 1 via cooperation between insulin and Wnt signaling
Mi-Hyun Kim, Jae-Hwan Jee, Sunyoung Park, Myung-Shik Lee, Kwang-Won Kim, Moon-Kyu Lee
Journal of Endocrinology.2014; 220(2): 117.     CrossRef
Predicting the DPP-IV Inhibitory ActivitypIC50Based on Their Physicochemical Properties
Tianhong Gu, Xiaoyan Yang, Minjie Li, Milin Wu, Qiang Su, Wencong Lu, Yuhui Zhang
BioMed Research International.2013; 2013: 1.     CrossRef
Exendin-4 Protects Against Sulfonylurea-Induced β-Cell Apoptosis
Ju-Young Kim, Dong-Mee Lim, Hyung-Seo Park, Chan-Il Moon, Kyung-Jin Choi, Seong-Kyu Lee, Haing-Woon Baik, Keun-Young Park, Byung-Joon Kim
Journal of Pharmacological Sciences.2012; 118(1): 65.     CrossRef
Retrospective Analysis on the Efficacy, Safety and Treatment Failure Group of Sitagliptin for Mean 10-Month Duration
Won Jun Kim, Cheol-Young Park, Eun Haeng Jeong, Jeong Youn Seo, Ji Soo Seol, Se Eun Park, Eun Jung Rhee, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim
Diabetes & Metabolism Journal.2011; 35(3): 290.     CrossRef